Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
NervGen Pharma to Participate in the H.C. Wainwright "HCW@Home" Series and the 2026 Bloom Burton & Co. Healthcare Investor Conference
-
UPDATE – The 100-Calorie Refresher Redefining Rosé: Introducing bubly wine refresher
-
Auction result of Treasury Bills - RIKV 26 0715 - RIKV 26 0916
-
Calavo Growers Declares Quarterly Dividend
-
Ministers and Members of Parliament at Paris Blockchain Week 2026: A Historic Signal for the Institutionalization of Crypto-Assets
-
Fredonia Mining Inc. Grants Stock Options and Formalizes Management Agreements
-
Ninepoint Partners Launching Expanded Suite of Single-Stock ETFs
-
BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology Partners
-
DEEP SEA MINERALS CORP. APPOINTS DAN MCCONNELL AS VICE PRESIDENT OF EXPLORATION
-
NorthStrive Biosciences Announces U.S. Arrival of EL-32 Working Cell Bank and Initiation of Manufacturing Optimization for Dual Myostatin Assets Targeting Muscle Preservation with GLP-1 Therapies in C
-
Orca Energy Group Announces Definitive Agreement to Divest Tanzanian Business
-
Bombardier Announces April 15, 2026 as the Start of its New Normal Course Issuer Bid
-
Glass House Brands Announces California Retail Joint Venture with Vireo Growth
-
Vireo Growth Announces California Retail Joint Venture with Glass House Brands
-
Hillman Acquires Delaney Hardware; Expands Pro Distribution Categories Adding Door Hardware
-
Newly Published U.S. Expert Consensus Aligns with MediWound’s Strategy for Chronic Wound Debridement
-
UPDATE – The 100-Calorie Refresher Redefining Rosé: Introducing bubly wine refresher
-
3D Systems Accelerates Production-Scale Additive Manufacturing with New High-Throughput Platform and Next-Generation Factory Software
-
Palvella Therapeutics Appoints John D. Doux, M.D., M.B.A., Dermatologist and Recognized Leader in Rare Skin Diseases, to Board of Directors
-
Allogene Therapeutics Reports Interim Futility Analysis from Pivotal ALPHA3 Trial Showing 58.3% MRD Clearance with Cemacabtagene Ansegedleucel (Cema-Cel) vs. 16.7% in Observation Arm in First-Line Con
-
ASP Isotopes Inc. Provides Business Update
-
Caliber and PURE Pickleball & Padel Announce Building Permit Approval for World’s Largest Indoor Pickleball and Padel Facility
-
National Healthcare Properties Announces Launch of Public Offering
-
urban-gro, Inc. (Nasdaq: UGRO) Announces Lanka Premier League Season 6 — Potential Record 600-Player Pool, World-Class Marquee Talent, and Expected Appointment of Chris Gayle as Global Brand Ambassa
-
From Milestone to Momentum: Kraig Biocraft Leadership Travels to South East Asia Following Record-Setting 1.3 Metric Ton Recombinant Spider Silk Cocoon Production Cycle
-
Sable Reports Drill Results Extending the Pyros Cu–Au–Mo Porphyry System, San Juan, Argentina
-
New Drilling Intersects 136 metres of 0.67 g/t Gold
-
Ongwe Minerals Discovers New Bedrock Anomaly at Its Belmont Prospect, Khorixas Gold Project in Namibia
-
Bonterra Energy Announces Approval of Its Second Normal Course Issuer Bid
-
Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621, a First-in-Class, Oral STAT6 Degrader for the Treatment of Moderate to Severe Asthma
-
Ocular Therapeutix™ Announces Additional Positive Week 52 Data from Landmark SOL-1 Phase 3 Trial of AXPAXLI™ in Wet AMD
-
Capstreet-backed SmartSights Names Michael Santoli Vice President, Enterprise Sales
-
NATPAT brings its first spray repellent to Target with the launch of Baby Buzz Spray
-
Americold Realty Trust, Inc. Sets Date for First Quarter 2026 Earnings Release and Conference Call
-
Eclipse Life Sciences Completes Enrollment in Phase 2 Study Evaluating EC-104 for Diabetic Macular Edema (DME)
-
CBAK Energy Achieves 2nd in 26650/26700 and 3rd in 32140 Cylindrical Cell Shipments in China
-
GXO Schedules First Quarter 2026 Earnings Conference Call for Wednesday, May 6, 2026
-
ImageneBio Announces $30 Million Private Placement
-
Spyre Announces Potential Best-in-Class SPY001 Part A Induction Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients
-
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Appointment of Glenn Tyson as the Company’s first Chief Commercial Officer
-
Soleo Health Opens New Ambulatory Infusion Center in Louisville, Kentucky
-
Aeluma Secures More Than $4 Million in Contracts for Quantum Materials and Lasers
-
Eldorado Gold Provides Q1 2026 Conference Call Details
-
Man Group PLC : Form 8.3 - JTC Plc
-
Man Group PLC : Form 8.3 - Senior plc
-
Man Group PLC : Form 8.3 - A consortium comprising LondonMetric Property plc and Schroder Real Estate Investment Trust Limited
-
Copenhagen Infrastructure Partners divests ownership of Summerfield Battery to Palisade Investment Partners
-
Signify share repurchase periodic update
-
OXB launches fast-track offering for AAV and lentiviral vector platforms, accelerating viral vector development and manufacture
-
Forløb af ordinær generalforsamling Investeringsforeningen Nordea Invest

